Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Spyre Therapeutics, Inc.

Clinical trials sponsored by Spyre Therapeutics, Inc., explained in plain language.

Spyre Therapeutics, Inc. SYRE NASDAQ

A biotechnology company developing antibody therapies for inflammatory bowel disease.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 4 Completed 1

Can a new injection tame the painful lumps of hidradenitis suppurativa?

Disease control Not yet recruiting

This phase 2 trial tests whether an investigational medicine called SPY072 can improve hidradenitis suppurativa (HS), a chronic skin condition causing painful lumps and tunnels. About 150 adults with moderate-to-severe HS who are already receiving standard care will be randomly a…

Phase: PHASE2 • Sponsor: Spyre Therapeutics, Inc. • Aim: Disease control

Last updated Aug 16, 2026 00:00 UTC